Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 224.00
Ask: 238.00
Change: 1.00 (0.43%)
Spread: 14.00 (6.25%)
Open: 230.00
High: 232.00
Low: 230.00
Prev. Close: 230.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funding Approval - G7 Central Bank

17 Sep 2019 07:00

RNS Number : 5225M
Spectra Systems Corporation
17 September 2019
 

Spectra Systems Corporation

("Spectra")

 Funding approved for New Quality Control Equipment for G7 Central Bank

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication and brand protection technologies, and gaming security software, is pleased to announce that it has received funding approval for a $1.3MM contract with a G7 central bank to deliver three advanced quality control units used in the manufacturing of banknotes with the Company's materials. The contract and its terms have been fully approved and its execution is scheduled for later this month. Engineering design of the units will commence in 2019 and the units will be delivered in 2020.

Supported by the profits from the new quality control hardware contract, the Company intends to accelerate its G7 material manufacturing throughout 2019 to provide resources for expected material demands related to sample and possible production requirements for a Request for Proposals from an Asian central bank received recently.

As a result of the G7 contract, Spectra anticipates that its profits for the year ending 31 December 2019 to significantly exceed market expectations.

The Company will be releasing its mid-year financial statements in week commencing 23 September, 2019.

 

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We are delighted that our long standing G7 customer has provided us with the opportunity to upgrade and replace the current equipment used in banknote production. This new equipment will support our continued sales of materials to our central bank customer for many years to come.

"We are also delighted that we are able to provide a second positive trading update for 2019 which is both reflective of an increasing product mix and includes new hardware sales which support the long term sales of our consumables."

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 WH Ireland Limited

Chris Fielding, Managing Director, Corporate Finance Tel: +44 (0) 20 7220 1650

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAPNKFSSNEFF
Date   Source Headline
3rd Apr 20247:00 amRNSCertified Circular Polymer Banknote Substrate
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
13th Mar 20243:07 pmRNSNotice of Results
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
6th Sep 20237:00 amRNSResults for the 6 months ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
14th Jun 20237:00 amRNSUpdate on Development Contracts
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
13th Mar 20237:00 amRNSNotice of Results
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSUpdate regarding Solaris
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Feb 20227:00 amRNSSpectra Introduces Covert Polymer Substrate
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.